FLGT - CIK 0001674930
The table below shows Fulgent Genetics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $50.19M | $55.14M | $97.47M | $79.51M | $164.89M | $87.43M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $84.76M | $69.02M | $51.13M | $52.75M | $138.91M | $183.86M |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $550.49M |
| $353.57M |
| $507.85M |
| $627.87M |
| $611.96M |
| $523.62M |
| Property, plant & equipment | $112.55M | $105.55M | $83.46M | $81.35M | $62.29M | $40.20M |
| Goodwill | $25.08M | $22.05M | $22.05M | $143.03M | $50.90M | - |
| Total assets | $1.21B | $1.22B | $1.24B | $1.39B | $1.28B | $700.46M |
| Accounts payable | $18.65M | $18.36M | $15.36M | $23.09M | $20.49M | $26.49M |
| Total current liabilities | $84.97M | $72.90M | $73.02M | $88.11M | $105.31M | $130.12M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $106.81M | $90.81M | $102.04M | $116.18M | $112.84M | $131.07M |
| Retained earnings | $529.95M | $590.47M | $633.17M | $801.00M | $657.60M | $150.88M |
| Total equity | $1.11B | $1.13B | $1.14B | $1.27B | $1.16B | $569.39M |